These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9114429)

  • 1. Determination of drug susceptibility of Mycobacterium tuberculosis through mycolic acid analysis.
    Garza-González E; Guerrero-Olazarán M; Tijerina-Menchaca R; Viader-Salvadó JM
    J Clin Microbiol; 1997 May; 35(5):1287-9. PubMed ID: 9114429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The mycolic acids analysis with HPLC technique in drug susceptibility testing of Mycobacterium tuberculosis strains].
    Walkiewicz R; Grubek-Jaworska H; Chazan R
    Pneumonol Alergol Pol; 2006; 74(1):89-94. PubMed ID: 17175985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid, standardized method for determination of Mycobacterium tuberculosis drug susceptibility by use of mycolic acid analysis.
    Parrish N; Osterhout G; Dionne K; Sweeney A; Kwiatkowski N; Carroll K; Jost KC; Dick J
    J Clin Microbiol; 2007 Dec; 45(12):3915-20. PubMed ID: 17913928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycolic acid index susceptibility method for Mycobacterium tuberculosis.
    Viader-Salvadó JM; Garza-González E; Valdez-Leal R; del Bosque-Moncayo MA; Tijerina-Menchaca R; Guerrero-Olazarán M
    J Clin Microbiol; 2001 Jul; 39(7):2642-5. PubMed ID: 11427584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and analysis of Mycobacterium tuberculosis mycolic acids.
    Vilchèze C; Jacobs WR
    Curr Protoc Microbiol; 2007 Jun; Chapter 10():Unit 10A.3. PubMed ID: 18770604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separation of Mycobacterium bovis BCG from Mycobacterium tuberculosis and Mycobacterium bovis by using high-performance liquid chromatography of mycolic acids.
    Floyd MM; Silcox VA; Jones WD; Butler WR; Kilburn JO
    J Clin Microbiol; 1992 May; 30(5):1327-30. PubMed ID: 1583141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cell-based screening system for detection of inhibitors toward mycobacterial cell wall core.
    Gao P; Guan Y; Song D; Xiao C
    J Antibiot (Tokyo); 2009 Jun; 62(6):315-8. PubMed ID: 19444301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-test: an alternative method for susceptibility testing of Mycobacterium tuberculosis.
    Akcali S; Cicek C; Surucuoglu S; Ozbakkaloglu B
    Med Princ Pract; 2005; 14(4):264-7. PubMed ID: 15961938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
    Akselband Y; Cabral C; Shapiro DS; McGrath P
    J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mycolic acids analysis from various species mycobacterium by high pressure liquid chromatography (HPLC)].
    Safianowska A; Walkiewicz R; Grubek-Jaworska H; Zwolska Z; Augustynowicz-Kopeć E; Glapiński J; Chazan R
    Pneumonol Alergol Pol; 2002; 70(3-4):130-8. PubMed ID: 12271960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the primary target for isoniazid in mycobacterial mycolic acid biosynthesis with Mycobacterium aurum A+.
    Wheeler PR; Anderson PM
    Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):451-7. PubMed ID: 8809032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Effect of DFC-2 on Mycolic Acid Biosynthesis in
    Kim S; Seo H; Mahmud HA; Islam MI; Kim YS; Lyu J; Nam KW; Lee BE; Lee KI; Song HY
    J Microbiol Biotechnol; 2017 Nov; 27(11):1932-1941. PubMed ID: 28870005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the in vitro activity of streptomycin against Mycobacterium tuberculosis.
    Ruiz P; Rodríguez-Cano F; Zerolo FJ; Casal M
    Microb Drug Resist; 2002; 8(2):147-9. PubMed ID: 12118520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorimetric method for determining MICs of antimicrobial agents for Mycobacterium tuberculosis.
    Yajko DM; Madej JJ; Lancaster MV; Sanders CA; Cawthon VL; Gee B; Babst A; Hadley WK
    J Clin Microbiol; 1995 Sep; 33(9):2324-7. PubMed ID: 7494021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of major slowly growing pathogenic mycobacteria and Mycobacterium gordonae by high-performance liquid chromatography of their mycolic acids.
    Butler WR; Kilburn JO
    J Clin Microbiol; 1988 Jan; 26(1):50-3. PubMed ID: 3125214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of receiver operating characteristic curves to assess the performance of a microdilution assay for determination of drug susceptibility of clinical isolates of Mycobacterium tuberculosis.
    Luna-Herrera J; Martínez-Cabrera G; Parra-Maldonado R; Enciso-Moreno JA; Torres-López J; Quesada-Pascual F; Delgadillo-Polanco R; Franzblau SG
    Eur J Clin Microbiol Infect Dis; 2003 Jan; 22(1):21-7. PubMed ID: 12582740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IQG-607 abrogates the synthesis of mycolic acids and displays intracellular activity against Mycobacterium tuberculosis in infected macrophages.
    Rodrigues-Junior VS; dos Santos Junior AA; Villela AD; Belardinelli JM; Morbidoni HR; Basso LA; Campos MM; Santos DS
    Int J Antimicrob Agents; 2014 Jan; 43(1):82-5. PubMed ID: 24139881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Commercial Kit SIRE Nitratase for detecting resistant Mycobacterium tuberculosis in Brazil.
    Miranda SS; Almeida IN; Lopes ML; Figueiredo JDR; Figueredo LJA; Kritski AL; Carvalho WDS; Mansur MFFO
    Rev Soc Bras Med Trop; 2017; 50(4):550-553. PubMed ID: 28954080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro effect of ursolic acid on the inhibition of Mycobacterium tuberculosis and its cell wall mycolic acid.
    Jyoti MA; Zerin T; Kim TH; Hwang TS; Jang WS; Nam KW; Song HY
    Pulm Pharmacol Ther; 2015 Aug; 33():17-24. PubMed ID: 26021818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of a novel antimycobacterial compound, N-octanesulfonylacetamide, and its effects on lipid and mycolic acid synthesis.
    Parrish NM; Houston T; Jones PB; Townsend C; Dick JD
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1143-50. PubMed ID: 11257028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.